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Objective:  This study investigated the effects of the ethanolic extract of Garcinia cambogia on 
ciprofloxacin – induced hepatotoxicity.
Method: Twenty (20) adult male Wistar rats were divided into four groups; Group A were given 
ciprofloxacin only (150 mg/kg b.w), Group B were given ciprofloxacin (150 mg/kg b.w) and extract (400 
mg/kg b.w) simultaneously, Group C were given extract only (400 mg/kg b.w) and Group D served as 
control and received 1.5ml of distilled water as placebo.  Serum and liver tissue were collected and 
processed for biochemical and histological studies respectively.
Results: The result of this work showed significantly elevated levels of aspartate transaminase (ASP), 
alkaline phosphatase (ALP) and alanine transaminase (ALT) in ciprofloxacin-treated rats compared to 
the  Garcinia  cambogia-treated  and  control  groups.  The histological analysis also showed distortion 
of the lobular architecture and presence of inflammatory cells within the sinusoids and hepatocellular 
apoptosis in Group A.
Conclusion: The results showed that Garcinia cambogia attenuates the toxic effects of ciprofloxacine on 
the liver.
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L'extrait éthanolique de garcinia cambogia protège le foie contre 
l'hépatotoxicité induite par la ciprofloxacine
Ukwenya V.O.
Resume
Objectif: Cette étude a examiné les effets de l 'extrait éthanolique de Garcinia cambogia sur l' 
hépatotoxicité induite par la ciprofloxacine.
Méthode: Vingt et un (21) rats Wistar mâles adultes ont été divisés en quatre groupes; Le groupe A 
recevait uniquement de la ciprofloxacine (150 mg / kg de poids corporel), le groupe B recevait la 
ciprofloxacine (150 mg / kg de poids corporel) et l'extrait (400 mg / kg de poids corporel) simultanément; 
le groupe C recevait uniquement de l'extrait (400 mg / kg de poids corporel) et le groupe D a servi de 
témoin et a reçu 1,5 ml d’eau distillée comme placebo. Le sérum et le tissu hépatique ont été recueillis et 
traités pour des études biochimiques et histologiques, respectivement.
Résultats: Les résultats de ce travail ont montré des taux significativement élevés d'aspartate 
transaminase (ASP), de phosphatase alcaline (ALP) et d'alanine transaminase (ALT) chez les rats traités à 
la ciprofloxacine par rapport aux groupes traités avec Garcinia cambogia et traité. L'analyse histologique a 
également montré une distorsion de l'architecture lobulaire et la présence de cellules inflammatoires au 
sein des sinusoïdes et de l'apoptose hépatocellulaire dans le groupe A.
Conclusion: les résultats ont montré que le Garcinia cambogia atténue les effets toxiques de la 
ciprofloxacine sur le foie.
Mots-clés: hépatotoxicité, architecture lobulaire, Garcinia cambogia, sérum, marqueurs enzymatiques
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G. cambogia powder was macerated in 4 litres of 
ethanol at room temperature. After 48 hours, the 
resulting solution was filtered using Whatman 
filter paper. Rotary evaporator (Labarato 4ooo, 
China) was used to concentrate the filtrate into a 
dark sticky mass which was freez-dried into 
powdery form using a freezer drier (Accumax, 
Indian). The extract was then dissolved in 
distilled water and administered at a dose of 400 
mg/kg body weight of the rats.
Animal Protocol
Twenty (20) healthy male Wistar rats 
weighing between 200-300g were housed in 
well-ventilated plastic cages and were provided 
with rat pellet and water ad libitum.
Experimental design
The rats were divided into four groups; 
Group A rats were given ciprofloxacin only (150 
mg/kg b.w), Group B rats were given 
ciprofloxacin (150 mg/kg b.w) and G. cambogia 
extract (400 mg/kg b.w) simultaneously, Group C 
rats were given the extract  only (400 mg/kg b.w) 
and Group D served as control and received 1.5ml 
of distilled water as placebo. Animals were 
weighed at the beginning and end of the 
experiment.  Administration was carried out for 
thirty (30) days after which the animals were 
sacrificed. Serum and liver tissue were collected 
and processed for biochemical and histological 
studies respectively.
Blood Collection and Serum Assay
After thirty days of administration, the 
animals were fasted overnight and administered 
mild anesthesia (chloroform). They were cut 
open by thoraco-abdominal incision and blood 
samples were collected via cardiac puncture into 
sterile bottles. The blood samples were taken to 
the laboratory where they were centrifuged and 
serum was drawn for analysis. Serum 
concentrations of alanine transaminase (ALP), 
alkaline phosphatse (ALP) and aspartate 
transaminase (AST) were determined using 
commercial kits (Randox Labs, United 
Kingdom).
Tissue Processing
The rats were cut open by thoraco-
abdominal incision. The livers were harvested 
and blotted dry. They were fixed in 10% formo-
saline. The fixed tissues were transferred to 
graded series of ethanol and then cleared in 
xylene. The tissues were then infiltrated in molten 
0paraffin wax in the oven at 58 C. Serial sections 
INTRODUCTION
Garcinia cambogia (G. cambogia) which 
can also be called G. afzelii or heckle is a 
dicotyledonous plant, an angiospermae 
belonging to the family Clusiaceae or Guttiferae 
(1).  It is commonly and usually known as bitter 
kola or male kola (1).  It is called bitter – kola 
because when the seed is chewed, it has a bitter 
astringent and resinous taste somewhat 
resembling that of raw coffee followed by slight 
sweetness (2). It has been reported to possess 
erythropoetic and anti-obesity effects (3), 
profertility effects (4) as well as ability to protect 
the testes from ciprofloxacin-induced toxicity 
(5).
Ciprofloxacin is a fluoroquinolone that is 
indicated for the management of acute 
uncomplicated cystitis or uncomplicated 
pyelonephritis caused by E.coli and complicated 
urinary tract infections (UTI) caused by a variety 
of pathogens (6). It has been discovered to have 
several toxic effects in the body. A lot of patients 
develop several side effects ranging from liver 
damage (7,8) to pancreatitis (9), to eye problems 
(10) among others and some of these side effects 
could be life-threatening. Despite all this, a large 
percentage of people still use this drug 
indiscriminately.
It has been established that ciprofloxacin 
causes liver damage including hepatitis, 
elevation of aspartate aminotransferase (AST) 
and alanin aminotransferase (ALT), acute hepatic 
necrosis or failure and cholestatic jaundice.  
There have been a lot of reports from different 
people who have used this drug and came up with 
side effects which were confirmed to be 
symptoms of liver failure.
Several studies have revealed the protective 
effects of G. cambogia in liver toxicity. G. 
cambogia has been reported to offer protection 
against carbon-tetrachloride induced liver 
damage (11). A study by Ates et al (12) showed 
that G. cambogia supplementation resulted in 
reduced fat infiltration in rats that were fed high 
lipid diet compared to the group that had high 
lipid diet without G. cambogia extract.
The aim of this study was to investigate the 
protective effect(s) of G. cambogia on 
ciprofloxacin- induced liver damage.
MATERIALS AND METHOD
Preparation of Extract
G. cambogia seeds were obtained from a 
local market at Iwo, Osun State, Nigeria and were 
shade-dried for two (2) weeks. The seeds were 
ground into fine powder using a grinder. 1600 g of 
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levels were significantly higher in groups 
administered ciprofloxacin. From the results 
obtained, treatment with ciprofloxacin produced 
an increase in the level of ALP. This is in 
agreement with the previous report that this 
increase suggest an enhancement of the activities 
of ALP by the drug and its metabolites (14). 
ALP is a membrane-bound enzyme that is 
usually used as a marker for the integrity of the 
plasma membrane and endoplasmic reticulum 
and an increase in ALP activities of the serum 
implies membrane damage to the tissues. 
Obaleye et al. also reported that the increase in the 
level of ALP may be as a result of stress imposed 
on the tissue by the drug, which might have 
resulted in the loss of the enzyme molecule 
through exudation into extracellular fluid (14). It 
was also inferred that, in a bid to offset this stress, 
the tissue may increase the de novo synthesis of 
ALP, thus accounting for the upsurge in ALP 
activities in this tissue (15, 16, 17).
The increased level of ALP in the group 
treated with ciprofloxacin (Group A) implies a 
compromised membrane integrity whereas, the 
noted decrement in activity of ALP in 
ciprofloxacin-G.cambogia combined treatment 
(Group B) may be indicative of membrane 
integrity restoration.
In a similar trend, treatment with 
ciprofloxacin showed significant increase in the 
level of ALT as compared to control.  This agrees 
with Obaleye et al., who attributed the increase to 
stimulation of the enzyme activities by the drugs 
and their metabolites consequent upon stress 
imposed on hepatic tissues by the drug (14).
Treatment with G.cambogia was 
associated with decrease in serum markers of 
hepatic toxicity. The levels of ALP and ALP in 
this study were significantly lower in the 
ciprofloxacin + G. cambogia group (Group B) 
and G. cambogia (Group C) compared to the 
cipro only group (Group A). This reflects the 
ability of the extract to mitigate liver damage and 
validates claims that it can be used to treat liver 
disorders due to its bioflavonoids content (18).
Histological features from cross-sections of 
extract-treated rats further corraborated the 
impact of G. cambogia. Hepatic tissue from 
Group A rats showed inflammatory features that 
included oedema, widened central veins, 
disrupted lobular architecture and shrinking, 
apoptic cells. These features were attenuated in 
groups B and C. G. cambogia-treated groups 
featured normal hepatocytes and cell cords and 
might be attributable to the antioxidant and free 
of 5µm thick were obtained from a solid block of 
tissue, fixed on clean slides and stained with 
haematoxylin and eosin stains and were analyzed 
using light microscopy.
Statistical analysis
Data collected were expressed as means 
±SEM. Analysis of data was carried out with a 
software, GraphPad Prism (California, USA) by 
means of one-way analysis of variance (ANOVA) 
to analyze statistical difference between means; 
P≤0.05 was considered significant.
 
RESULTS
Enzymes of Liver Function
Data for the changes in the ALP and ALT 
levels of treated and control rats are shown in the 
charts below.  The levels of ALP of Group A 
(2139 U/I) was significantly higher than C 
(1578.72 U/I and D (1524.62 U/I). It is also 
higher than in Group B but not significant (Fig. 
1). The levels of ALT for Groups A (230 U/I) was 
significantly higher than in B (193 U/I), C 
(181U/I) and Group D (187 U/I).  (Fig. 2). Data 
for aspartate (ASP) levels are presented in figure 
3. The levels of AST of Group A (863U/I) was 
significantly higher than B (715), C (655 U/I and 
D (500 U/I). The value recorded for Group B and 
C were statistically higher than D (P<0.05).
Histology
Micrographs of hepatic tissues from Group 
A were marked by distortion of the lobular 
architecture, distention of the central veins, 
diffused swelling of hepatocytes (indicative of 
apoptosis) and presence of inflammatory cells in 
the sinusoids (Fig 4A). In Group B, the classical 
liver lobule was undisrupted although the central 
vein and portal triad showed expansion.  It was 
also observed that the central vein contained 
granulated cytoplasmic content (Fig 4B). 
Sections from Group C (Fig 4C) showed hepatic 
tissue with classical lobule having intact 
cytoarchitecture. The parenchyma features were 
comparable to the control group D (Fig 4D).
DISCUSSION
Injured hepatocytes release AST, ALP and 
ALT into the bloodstream. The classical 
laboratory findings of hepatotoxicity are 
elevation in AST, ALP and ALT (13). Many 
studies involving the experimental induction of 
liver injury with several drugs and chemicals 
have reported an upsurge in the levels of these 
markers of liver toxicity, especially in ALT level. 
In this study, also, serum ASP, ALT and AST 
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radicals-scavenging properties of the extract. 
This is similar to the findings reported in 
literature (19).
Results from this study showed that the 
administration of 150 mg/kg b.w of ciprofloxacin 
in adult male Wistar rats was associated with 
increase in serum levels of ALP, ALT and ASP 
and features of inflammation in hepatic tissue. 
However, treatment with 400 mg/kg b.w of G. 
cambogia ameliorated the toxic effects of 
ciprofloxacin administration, evidenced by 
reduction in hepatic damage serum markers and 
improvement of histological features.
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Figure 1. Changes in the level of ALP of treated and control rats. N=5.  
*Statistically different from C and D.  
+
Not statistically different from A.  
A= Ciprofloxacin only;  
B= Ciprofloxacin+ Garcinia cambogia;  
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Figure 2. Changes in the level of ALT of treated and control rats. N=5.  
*Statistically different from  B, C and D. 
A= Ciprofloxacin only; 
B= Ciprofloxacin+ Garcinia cambogia; 
C= Garcinia cambogia only; 
D= Control 
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Figure 3. Changes in the level of AST of treated and control rats. N=5.  
*Statistically different from B, C and D.  
+ 
Statistically different from D.  
A= Ciprofloxacin only; 
B= Ciprofloxacin+ Garcinia cambogia; 
C= Garcinia cambogia only; 
D= Control. 
Figure 4. A. Cross-section from Group A (Cipro only) rats showing pathological features. 
Observe the disruption of lobular architecture and the widened central  vein (CV), 
arrows indicate shrinking, apoptotic cells. B (Cipro + G.cambogia) sections showed normal central veins (CV) 
a n d  w i d e n e d  s i n u s o i d s  ( a r r o w s )  w i t h  t h e  p r e s e r v a t i o n  o f  l o b u l a r  a r c h i t e c t u r e .  
Sections from Groups C (G.cambogia) and D (control) features normal lobular architecture 
with intact hepatocytes and cords.  
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